These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21884701)

  • 1. MMPs 2 and 9 are essential for coronary collateral growth and are prominently regulated by p38 MAPK.
    Dodd T; Jadhav R; Wiggins L; Stewart J; Smith E; Russell JC; Rocic P
    J Mol Cell Cardiol; 2011 Dec; 51(6):1015-25. PubMed ID: 21884701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-sensitive Akt and Src regulate coronary collateral growth in metabolic syndrome.
    Reed R; Potter B; Smith E; Jadhav R; Villalta P; Jo H; Rocic P
    Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1811-21. PubMed ID: 19376806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth.
    Rocic P; Kolz C; Reed R; Potter B; Chilian WM
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2729-36. PubMed ID: 17308014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
    J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin.
    Dodd T; Wiggins L; Hutcheson R; Smith E; Musiyenko A; Hysell B; Russell JC; Rocic P
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1339-49. PubMed ID: 23599440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction.
    Joseph G; Soler A; Hutcheson R; Hunter I; Bradford C; Hutcheson B; Gotlinger KH; Jiang H; Falck JR; Proctor S; Schwartzman ML; Rocic P
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H528-H540. PubMed ID: 28011587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of the matrix metalloproteinase-2 activation system in arteries by tensile stress. Involvement of the p38 MAP-kinase pathway.
    Grabellus F; Worm K; Schmid KW
    Pathol Res Pract; 2007; 203(3):135-43. PubMed ID: 17306932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p38 mitogen-activated protein kinase inhibition decreases TNFalpha secretion and protects against left ventricular remodeling in rats with myocardial ischemia.
    Yin H; Zhang J; Lin H; Wang R; Qiao Y; Wang B; Liu F
    Inflammation; 2008 Apr; 31(2):65-73. PubMed ID: 17943427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-21 normalizes vascular smooth muscle proliferation and improves coronary collateral growth in metabolic syndrome.
    Hutcheson R; Chaplin J; Hutcheson B; Borthwick F; Proctor S; Gebb S; Jadhav R; Smith E; Russell JC; Rocic P
    FASEB J; 2014 Sep; 28(9):4088-99. PubMed ID: 24903275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation.
    Cortez DM; Feldman MD; Mummidi S; Valente AJ; Steffensen B; Vincenti M; Barnes JL; Chandrasekar B
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3356-65. PubMed ID: 17921324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTGF is increased in basal deposits and regulates matrix production through the ERK (p42/p44mapk) MAPK and the p38 MAPK signaling pathways.
    Nagai N; Klimava A; Lee WH; Izumi-Nagai K; Handa JT
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1903-10. PubMed ID: 19011018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of SB203580, a p38 MAPK Inhibitor, Reduced the Expression of MMP9, and Relieved Neurologic Severity in the Experimental Autoimmune Neuritis (EAN) in Rats.
    Sun Y; Chen H; Ma S; Liang L; Zheng Y; Guo X; Wang M; Wang W; Li G; Zhong D
    Neurochem Res; 2015 Jul; 40(7):1410-20. PubMed ID: 25998885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of taurine against renal ischemia/reperfusion injury in rats by inhibition of gelatinases, MMP-2 and MMP-9, and p38 mitogen-activated protein kinase signaling.
    Cavdar Z; Ural C; Celik A; Arslan S; Terzioglu G; Ozbal S; Yildiz S; Ergur UB; Guneli E; Camsari T; Akdogan G
    Biotech Histochem; 2017; 92(7):524-535. PubMed ID: 28895768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical force enhances MMP-2 activation via p38 signaling pathway in human retinal pigment epithelial cells.
    Hou X; Han QH; Hu D; Tian L; Guo CM; Du HJ; Zhang P; Wang YS; Hui YN
    Graefes Arch Clin Exp Ophthalmol; 2009 Nov; 247(11):1477-86. PubMed ID: 19590887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p38 MAP kinase mediates transforming-growth factor-β1-induced upregulation of matrix metalloproteinase-9 but not -2 in human brain pericytes.
    Takahashi Y; Maki T; Liang AC; Itoh K; Lok J; Osumi N; Arai K
    Brain Res; 2014 Dec; 1593():1-8. PubMed ID: 25451097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-21-mediated decreased neutrophil apoptosis is a determinant of impaired coronary collateral growth in metabolic syndrome.
    Hutcheson R; Terry R; Hutcheson B; Jadhav R; Chaplin J; Smith E; Barrington R; Proctor SD; Rocic P
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(11):H1323-35. PubMed ID: 25840830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide and p38 MAP kinase mediate shear stress-dependent inhibition of MMP-2 production in microvascular endothelial cells.
    Milkiewicz M; Kelland C; Colgan S; Haas TL
    J Cell Physiol; 2006 Jul; 208(1):229-37. PubMed ID: 16575906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin type I receptor blockade in conjunction with enhanced Akt activation restores coronary collateral growth in the metabolic syndrome.
    Jadhav R; Dodd T; Smith E; Bailey E; Delucia AL; Russell JC; Madison R; Potter B; Walsh K; Jo H; Rocic P
    Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1938-49. PubMed ID: 21335466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity.
    Kumar B; Koul S; Petersen J; Khandrika L; Hwa JS; Meacham RB; Wilson S; Koul HK
    Cancer Res; 2010 Jan; 70(2):832-41. PubMed ID: 20068172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasudil inhibits LPS-induced migration of retinal microglial cells via regulating p38-MAPK signaling pathway.
    Xu F; Xu Y; Zhu L; Rao P; Wen J; Sang Y; Shang F; Liu Y
    Mol Vis; 2016; 22():836-46. PubMed ID: 27441000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.